Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1-Reference-Cited by-同舟云学术

Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1

Published:2023-05 Issue:5 Volume:56 Page:1046-1063.e7
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Seeling Michaela,Pöhnl Matthias,Kara Sibel,Horstmann Nathalie,Riemer Carolina,Wöhner Miriam,Liang Chunguang,Brückner Christin,Eiring Patrick,Werner Anja,Biburger Markus,Altmann Leon,Schneider Martin,Amon Lukas,Lehmann Christian H.K.,Lee Sooyeon,Kunz Meik,Dudziak Diana,Schett Georg,Bäuerle Tobias,Lux Anja,Tuckermann Jan,Vögtle Timo,Nieswandt Bernhardt,Sauer Markus,Böckmann Rainer A.,Nimmerjahn Falk^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference81 articles.

1. Mechanisms of autoantibody-induced pathology;Ludwig;Front. Immunol.,2017

2. Autoimmunity;Yamamoto;Curr. Opin. Immunol.,2010

3. B-cell self-tolerance in humans;Wardemann;Adv. Immunol.,2007

4. Regulatory B cells: origin, phenotype, and function;Rosser;Immunity,2015

5. Natural regulatory plasma cells;Fillatreau;Curr. Opin. Immunol.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: A comprehensive systematic review;Current Research in Translational Medicine;2024-12

2. Molecular probes for super-resolution imaging of drug dynamics;Advanced Drug Delivery Reviews;2024-07

3. Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024;International Archives of Allergy and Immunology;2024-06-07

4. Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB;Journal of Medicinal Chemistry;2024-04-19

5. Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy;Antibodies;2024-04-18